Vanguard Group Inc Amneal Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 17,551,391 shares of AMRX stock, worth $158 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,551,391
Previous 15,762,727
11.35%
Holding current value
$158 Million
Previous $132 Million
7.49%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AMRX
# of Institutions
247Shares Held
144MCall Options Held
194KPut Options Held
49.3K-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$106 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$102 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$50.7 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.3MShares$47.8 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.37B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...